Literature DB >> 15721760

Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.

Paul McQuade1, Katherine E Martin, Thomas C Castle, Michael J Went, Philip J Blower, Michael J Welch, Jason S Lewis.   

Abstract

BACKGROUND: Cu-diacetyl-bis(N4-methylthiosemicarbazone) [Cu-ATSM], although excellent for oncology applications, may not be suitable for delineating cardiovascular or neurological hypoxia. For this reason, new Cu hypoxia positron emission tomography (PET) imaging agents are being examined to search for a higher selectivity for hypoxic or ischemic tissue at higher oxygen concentrations found in these tissues. Two approaches are to increase alkylation or to replace the sulfur atoms with selenium, resulting in the formation of selenosemicarbazones.
METHODS: Three 64Cu-labeled selenosemicarbazone complexes were synthesized and one was screened for hypoxia selectivity in vitro using EMT-6 mouse mammary carcinoma cells. Rodent biodistribution and small animal PET images were obtained from BALB/c mice implanted with EMT-6 tumors. One alkylated thiosemicarbazone was synthesized and examined.
RESULTS: Of the three bis(selenosemicarbazone) ligands synthesized and examined, only 64Cu-diacetyl-bis(selenosemicarbazone) [64Cu-ASSM] was isolated in high-enough radiochemical purity to undertake cell uptake experiments where uptake was shown to be independent of oxygen concentration. The bis(thiosemicarbazone) complex synthesized, 64Cu-diacetyl-bis(N4-ethylthiosemicarbazone) [64Cu-ATSE], showed hypoxia selectivity similar to 64Cu-ATSM although at a higher oxygen concentration. Biodistribution studies for 64Cu-ASSM and 64Cu-ATSE showed high tumor uptake at 20 min (64Cu-ASSM, 10.33+/-0.78% ID/g; 64Cu-ATSE, 7.71+/-0.46% ID/g). PET images of EMT-6 tumor-bearing mice visualized the tumor with 64Cu-ATSE and revealed hypoxia selectivity consistent with the in vitro data.
CONCLUSION: Of the compounds synthesized, only 64Cu-ASSM and 64Cu-ATSE could be examined in vitro and in vivo. Although the stability of bis(selenosemicarbazone) complexes increased upon addition of methyl groups to the diimine backbone, the fully alkylated species, 64Cu-ASSM, demonstrated no hypoxia selectivity. However, the additional alkylation present in Cu-ATSE modifies the hypoxia selectivity and in vivo properties when compared with Cu-ATSM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721760     DOI: 10.1016/j.nucmedbio.2004.10.004

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  13 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens.

Authors:  Karrera Y Djoko; Cheryl-lynn Y Ong; Mark J Walker; Alastair G McEwan
Journal:  J Biol Chem       Date:  2015-06-08       Impact factor: 5.157

Review 3.  PET imaging of cardiac hypoxia: opportunities and challenges.

Authors:  M G Handley; R A Medina; E Nagel; P J Blower; R Southworth
Journal:  J Mol Cell Cardiol       Date:  2011-07-14       Impact factor: 5.000

4.  Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.

Authors:  Paul D Bonnitcha; Simon R Bayly; Mark B M Theobald; Helen M Betts; Jason S Lewis; Jonathan R Dilworth
Journal:  J Inorg Biochem       Date:  2009-10-24       Impact factor: 4.155

5.  In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.

Authors:  Paul D Bonnitcha; Amy L Vāvere; Jason S Lewis; Jonathan R Dilworth
Journal:  J Med Chem       Date:  2008-04-17       Impact factor: 7.446

6.  Radiobiological effects of hypoxia-dependent uptake of 64Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells.

Authors:  Amanda J Weeks; Rowena L Paul; Paul K Marsden; Philip J Blower; Daniel R Lloyd
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-14       Impact factor: 9.236

7.  Copper(II) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysis.

Authors:  Jon D Silversides; Cheryll C Allan; Stephen J Archibald
Journal:  Dalton Trans       Date:  2007-02-01       Impact factor: 4.390

8.  Opportunities and challenges for metal chemistry in molecular imaging: from gamma camera imaging to PET and multimodality imaging.

Authors:  Richard Southworth; Rafael Torres Martin de Rosales; Levente K Meszaros; Michelle T Ma; Gregory E D Mullen; Gilbert Fruhwirth; Jennifer D Young; Cinzia Imberti; Julia Bagunya-Torres; Erica Andreozzi; Philip J Blower
Journal:  Adv Inorg Chem       Date:  2015-11-16       Impact factor: 3.282

9.  Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.

Authors:  Maxwell G Handley; Rodolfo A Medina; Erika Mariotti; Gavin D Kenny; Karen P Shaw; Ran Yan; Thomas R Eykyn; Philip J Blower; Richard Southworth
Journal:  J Nucl Med       Date:  2014-01-13       Impact factor: 10.057

Review 10.  Development of copper based drugs, radiopharmaceuticals and medical materials.

Authors:  Paweł Szymański; Tomasz Frączek; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Biometals       Date:  2012-08-23       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.